Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.22.2.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue:        
Total revenue $ 1,323 $ 0 $ 2,010 $ 12,050
Operating expenses:        
Cost of product revenues 144 0 243 0
Research and development 7,131 4,734 12,980 11,682
Selling, general and administrative 15,786 12,774 30,262 19,468
Total operating expenses 23,061 17,508 43,485 31,150
Loss from operations (21,738) (17,508) (41,475) (19,100)
Other expense (income):        
Loss on extinguishment of debt 0 0 0 2,725
Amortization of debt issuance costs and discount 421 269 799 525
Interest income (181) (6) (193) (12)
Interest expense 1,231 445 2,291 659
Other income 0 (3) (2) (2)
Warrant liabilities fair value adjustment (9,682) (15,271) (19,712) (16,567)
Derivative liabilities fair value adjustment (182) (462) (1,162) (372)
Total other income (8,393) (15,028) (17,979) (13,044)
Loss before taxes (13,345) (2,480) (23,496) (6,056)
Income tax benefit 0 (4,138) (4,700) (3,038)
Net (loss) income $ (13,345) $ 1,658 $ (18,796) $ (3,018)
Net (loss) income per share attributable to common stockholders – basic        
Net (loss) income per share – basic $ (0.31) $ 0.06 $ (0.50) $ (0.12)
Net loss per share attributable to common stockholders – diluted        
Net loss per share – diluted $ (0.31) $ (0.22) $ (0.50) $ (0.44)
Weighted average common shares outstanding – basic and diluted        
Basic 43,285,232 26,015,292 37,647,535 25,909,457
Diluted 43,285,232 26,487,973 37,647,535 26,505,808
Product Revenue, Net        
Revenue:        
Total revenue $ 1,323 $ 0 $ 2,010 $ 0
License Agreement Revenue        
Revenue:        
Total revenue $ 0 $ 0 $ 0 $ 12,050